Intracellular Aβ and C99 aggregates induce mitochondria-dependent cell death in human neuroglioma H4 cells through recruitment of the 20S proteasome subunits

Brain Research

Volumn 1273, Issue , 2009, Pages 1-8

  Park, Hyo Jin ^a,b   Kim, Sang Soo ^b   Kang, Seongman ^a   Rhim, Hyangshuk ^b  

^a Korea University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Alzheimer's disease; Amyloid beta (A ); C99; Human neuroglioma H4 cell; Mitochondria dependent cell death; Proteasome

Indexed keywords

AMYLOID BETA PROTEIN; CELL PROTEIN; CYTOCHROME C; GREEN FLUORESCENT PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEASOME; PROTEIN BAX; PROTEIN SUBUNIT; SERINE PROTEINASE OMI; AMYLOID PRECURSOR PROTEIN; APOPTOSIS REGULATORY PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; PEPTIDE FRAGMENT;

ARTICLE; ASSAY; CELL DEATH; CELL STRAIN HEK293; CELL TYPE; CYTOSOL; EMBRYO; HUMAN; HUMAN CELL; HUMAN EMBRYO; IMMUNOFLUORESCENCE TEST; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN SECRETION; ALZHEIMER DISEASE; CELL INCLUSION; CELL LINE; ENERGY METABOLISM; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; METABOLISM; NERVE CELL; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UBIQUITINATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL LINE; CELL LINE, TUMOR; CYTOSOL; ENERGY METABOLISM; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; GREEN FLUORESCENT PROTEINS; HUMANS; INCLUSION BODIES; MITOCHONDRIA; NEURONS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITINATION;

EID: 67349132288     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.04.001     Document Type: Article

References (31)

1. Almeida C.G., Takahashi R.H., and Gouras G.K. Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J. Neurosci. 26 (2006) 4277-4288
2. Andreatta C., Nahreini P., Hovland A.R., Kumar B., Edwards-Prasad J., and Prasad K.N. Use of short-lived green fluorescent protein for the detection of proteasome inhibition. Biotechniques 30 (2001) 656-660
3. Blandini F., Sinforiani E., Pacchetti C., Samuele A., Bazzini E., Zangaglia R., Nappi G., and Martignoni E. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology 66 (2006) 529-534
4. Cecarini V., Bonfili L., Amici M., Angeletti M., Keller J.N., and Eleuteri A.M. Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes. Brain Res. 1209 (2008) 8-18
5. Chai Y., Koppenhafer S.L., Shoesmith S.J., Perez M.K., and Paulson H.L. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8 (1999) 673-682
6. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., and Green D.R. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303 (2004) 1010-1014
7. Cory S., and Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev., Cancer 2 (2002) 647-656
8. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., and Relkin N.R. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156 (2000) 15-20
9. Hansson Petersen C.A., Alikhani N., Behbahani H., Wiehager B., Pavlov P.F., Alafuzoff I., Leinonen V., Ito A., Winblad B., Glaser E., and Ankarcrona M. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 13145-13150
10. Hartmann T. Intracellular biology of Alzheimer's disease amyloid beta peptide. Eur. Arch. Psychiatry Clin. Neurosci. 249 (1999) 291-298
11. Kienlen-Campard P., Miolet S., Tasiaux B., and Octave J.N. Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J. Biol. Chem. 277 (2002) 15666-15670
12. Knauer M.F., Soreghan B., Burdick D., Kosmoski J., and Glabe C.G. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 7437-7441
13. Li B., and Dou Q.P. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3850-3855
14. Lopes U.G., Erhardt P., Yao R., and Cooper G.M. p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272 (1997) 12893-12896
15. Meredith S.C. Protein denaturation and aggregation: cellular responses to denatured and aggregated proteins. Ann. N.Y. Acad. Sci. 1066 (2006) 181-221
16. Mochizuki A., Tamaoka A., Shimohata A., Komatsuzaki Y., and Shoji S. Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease. Lancet 355 (2000) 42-43
17. Nahreini P., Andreatta C., and Prasad K.N. Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells. Cell Mol. Neurobiol. 21 (2001) 509-521
18. Nakaso K., Yoshimoto Y., Yano H., Takeshima T., and Nakashima K. p53-mediated mitochondrial dysfunction by proteasome inhibition in dopaminergic SH-SY5Y cells. Neurosci. Lett. 354 (2004) 213-216
19. Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., and Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26 (2006) 10129-10140
20. Oh S., Hong H.S., Hwang E., Sim H.J., Lee W., Shin S.J., and Mook-Jung I. Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech. Ageing Dev. 126 (2005) 1292-1299
21. Ohyagi Y., Asahara H., Chui D.H., Tsuruta Y., Sakae N., Miyoshi K., Yamada T., Kikuchi H., Taniwaki T., Murai H., Ikezoe K., Furuya H., Kawarabayashi T., Shoji M., Checler F., Iwaki T., Makifuchi T., Takeda K., Kira J., and Tabira T. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. FASEB J. 19 (2005) 255-257
22. Park H.J., Choi J.Y., Seong Y.M., Han C., Yoon S.J., Kang S., and Rhim H. Antigenicity of the region encoded by exon8 of the human serine protease, HtrA2/Omi, is associated with its protein solubility. Biotechnol. Lett. 25 (2003) 1597-1603
23. Park H.J., Seong Y.M., Choi J.Y., Kang S., and Rhim H. Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi. Neurosci. Lett. 357 (2004) 63-67
24. Park H.J., Kim S.S., Seong Y.M., Kim K.H., Goo H.G., Yoon E.J., Min do S., Kang S., and Rhim H. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. J. Biol. Chem. 281 (2006) 34277-34287
25. Park Y., Hong S., Kim S.J., and Kang S. Proteasome function is inhibited by polyglutamine-expanded ataxin-1, the SCA1 gene product. Mol. Cells 19 (2005) 23-30
26. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
27. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 (1999) A23-31
28. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., and Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8 (2001) 613-621
29. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., Pradier L., Beyreuther K., and Bayer T.A. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306 (2001) 116-120
30. Wirths O., Multhaup G., and Bayer T.A. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide-the first step of a fatal cascade. J. Neurochem. 91 (2004) 513-520
31. Yamaguchi H., Bhalla K., and Wang H.G. Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria. Cancer Res. 63 (2003) 1483-1489